Dragon Pharmaceutical Inc., Shanxi Datong Guangming Pharmaceutical Co. Ltd. deal

DDD sold its biotech division to Shanxi Datong for $2.1 million. The division's sole product is injectable erythropoietin (EPO), which had sales of US$1 million in 1H07. DDD is now a small molecule ge...